Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.

@article{Dossenbach2005ResponseAR,
  title={Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.},
  author={Martin R K Dossenbach and C{\'e}sar Augusto Arango-D{\'a}vila and Hernan Silva Ibarra and Eric Landa and J Timoner Aguilar and Osvaldo Caro and Joanna Leadbetter and Sheila Seleri Marques Assunç{\~a}o},
  journal={The Journal of clinical psychiatry},
  year={2005},
  volume={66 8},
  pages={1021-30}
}
OBJECTIVE The primary aim of this study was to compare the effectiveness of 12 months' treatment with olanzapine, risperidone, quetiapine, or haloperidol in preventing relapse of schizophrenia. The study also examined other measures of clinical effectiveness and tolerability. METHOD Outpatients with schizophrenia (ICD-10 or DSM-IV), who initiated or changed antipsychotic treatment, entered this 3-year, naturalistic, prospective, observational study between November 2000 and December 2001. At… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 43 extracted citations

Similar Papers

Loading similar papers…